Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
株式のランク #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
株価
$99.32
時価総額
$48.20B
変化(1日)
0.98%
変化(1年)
-32.14%
AU
取引 CSL Limited (CSL)

カテゴリー

CSL Limited(CSL)の配当利回りの履歴
CSL Limited(銘柄コード: CSL)の配当利回り(TTM)は2024-06-30時点で1.35%です。
過去5年間の平均配当利回り: 1.54%
CSL Limited(CSL)の2000から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
2026 (TTM) 3.00% 59.57%
2025 1.88% 39.26%
2024 1.35% -25.41%
2023 1.81% 9.70%
2022 1.65% 66.67%
2021 0.99% 41.43%
2020 0.70% -39.13%
2019 1.15% 16.16%
2018 0.99% 2.06%
2017 0.97% -37.01%
2016 1.54% 18.46%
2015 1.30% -14.47%
2014 1.52% -7.88%
2013 1.65% -21.05%
2012 2.09% -19.62%
2011 2.60% 31.31%
2010 1.98% 47.76%
2009 1.34% 26.42%
2008 1.06% 23.26%
2007 0.86% -8.51%
2006 0.94% 28.77%
2005 0.73% 65.91%
2004 0.44% -76.84%
2003 1.90% 533.33%
2002 0.30% 15.38%
2001 0.26% -35.00%
2000 0.40% 0.00%
類似企業または競合他社の配当利回り(TTM)